Home › Funds › Penn Capital Management Company, LLC › AMRX
Penn Capital Management Company, LLC position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Penn Capital Management Company, LLC reported holding 1,181,176 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$20.5M, representing 1.30% of its reported portfolio and ranking #27 among its reported holdings. Penn Capital Management Company, LLC has disclosed AMRX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Penn Capital Management Company, LLC's AMRX position evolved
Penn Capital Management Company, LLC first disclosed a stake in AMRX in Q4 2025 at 1,001,951 shares (US$12.7M). The position peaked in Q2 2026 at 1,181,176 shares, worth US$20.5M. Across 3 filings, Penn Capital Management Company, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,181,176 shares valued at US$20.5M — a reduction of -14,897 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.00M | $12.66M | New |
| Q1 2026 | 1.20M | $14.90M | Add |
| Q2 2026 | 1.18M | $20.48M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMRX and 13F data
AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 47 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$213.4M), Rubric Capital Management LP (US$176.0M), Nantahala Capital Management, LLC (US$39.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMRX
- TPG GP A, LLC 12.33M sh · $213.41M · Q2 2026
- Rubric Capital Management LP 10.17M sh · $176.02M · Q2 2026
- Nantahala Capital Management, LLC 2.27M sh · $39.27M · Q2 2026
- Westshore Wealth, LLC 1.37M sh · $23.65M · Q2 2026
- BlackBarn Capital Partners LP 1.30M sh · $22.50M · Q2 2026
- TUCKER ASSET MANAGEMENT LLC 1.01M sh · $17.50M · Q2 2026
- Phocas Financial Corp. 819.48K sh · $14.19M · Q2 2026
More on Penn Capital Management Company, LLC
FAQ
How long has Penn Capital Management Company, LLC held AMRX?
Penn Capital Management Company, LLC has disclosed AMRX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Penn Capital Management Company, LLC's current position in AMRX?
As of Q2 2026, Penn Capital Management Company, LLC holds 1.18M shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $20.48M, representing 1.30% of its reported portfolio and ranking #27.
Has Penn Capital Management Company, LLC been buying or selling AMRX?
In the latest 13F filing (Q2 2026), Penn Capital Management Company, LLC reduced its position in AMRX. The position peaked in Q2 2026 at 1.18M shares.
Which other funds hold AMRX?
Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Nantahala Capital Management, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.